HYFT Stock Analysis: Buy, Sell, or Hold?
HYFT - MindWalk Holdings Corp. Common Stock
$1.62
-0.18 (-10.00%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Dec 15, 2025
0d
Get Alerted When HYFT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called HYFT this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: HYFT is down 28.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: HYFT is down 28.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: HYFT is currently trading at $1.62, which is considered oversold relative to its 30-day fair value range of $1.77 to $2.44. From a valuation perspective, the stock is trading at a discount (Forward PE: 81.8) compared to its historical average (103.4). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HYFT is in a uptrend. The price is currently testing key support at $1.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+122.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, HYFT is in a uptrend. The price is currently testing key support at $1.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 10.0% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+122.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.77 -
$2.44
Company Quality Score
41/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
Protect Your Profits
Holding HYFT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-10.0%)
- BULLISH: Trading 122.2% below Wall St target ($4.00)
- WARNING: Recommendation downgraded due to -28.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.77 -
$2.44
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.37
(22.7%)
Support & Resistance Levels
Support Level
$1.60
Resistance Level
$2.39
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
81.82
Wall Street Target
$4.00
(+122.2%)
Revenue Growth (YoY)
27.8%
Profit Margin
-115.8%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
81.8 vs 103.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$1.67
(-8%)
2-Year Target
$1.54
(-14%)
3-Year Target
$1.42
(-21%)
3-Yr Target (if PE normalizes)
(PE: 82→103)
$1.80
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 81.8 to 103.4
Stabilization Target:
$2.27
(+26.4%)
PE Expansion Potential:
+26.4%
Last updated: January 31, 2026 7:58 AM ET
Data refreshes hourly during market hours. Next update: 8:58 AM
Data refreshes hourly during market hours. Next update: 8:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYFT showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$141 | 59 HOLD |
Advanced HYFT Option Strategies
Professional options setups generated by AI based on today's HYFT price and gamma walls.